Directa Plus slumps on warning of administration risk unless funding talks succeed

4 days ago 3

Proactive

Mon, March 30, 2026 astatine 4:15 AM CDT 1 min read

Directa Plus slumps connected  informing  of medication  hazard  unless backing  talks succeed

Directa Plus slumps connected informing of medication hazard unless backing talks succeed Proactive uses images sourced from Shutterstock

Directa Plus PLC (AIM:DCTA, OTC:DTPKF) shares fell 17.5% to 7.01p aft the graphene products institution warned it could beryllium placed into medication if it fails to unafraid caller backing wrong weeks.

The AIM-listed radical said it was successful precocious discussions with an unnamed organization capitalist for a backing installation of up to £2.5 cardinal to widen its currency runway, but cautioned determination was "no certainty immoderate backing transaction volition beryllium concluded".

The institution had been successful abstracted talks with US concern steadfast Nant Capital implicit a non-dilutive indebtedness but said those discussions had breached down without agreement.

As revealed successful January, Directa closed 2025 with gross currency of €1.5 million, down from €5 million a twelvemonth earlier, giving it an effectual runway lone into aboriginal May.

The institution said that if nary further backing is secured, "it is highly apt that this volition effect successful the institution and the radical not being a going concern" and that directors would person to see placing it into administration.

The projected installation would necessitate shareholder support to proceed.

The committee said it was besides pursuing the merchantability of non-strategic onshore held by its Romanian biology remediation subsidiary Setcar, estimated to beryllium worthy astatine slightest €0.5 million, and evaluating broader options for the business, including a imaginable disposal of Setcar itself.

Read Entire Article